Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Guoliang Xing, PhD
Machine Learning Technologies for Advancing Digital Biomarkers for Alzheimer's Disease
Larry Baum, PhD
Testing 17-AAG for Treating Fronto-Temporal Dementia
A GuideStar-Rated Charity
© Copyright 2025. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).